DEFA14A: Blue Ridge Bankshares Updates on Private Placement with Shareholder Richard T. Spurzem

Blue Ridge Bankshares announces the closing of a private placement with shareholder Richard T. Spurzem, involving the issuance of common stock, preferred stock, and warrants for approximately $11.6 million.

Summary

• Blue Ridge Bankshares, Inc. has updated its proxy statement regarding the Special Meeting of Shareholders scheduled for June 20, 2024.
• The update concerns the closing of a private placement of securities with shareholder Richard T. Spurzem.
• On June 13, 2024, the company issued 290,000 shares of common stock, 1,140 shares of Series B Preferred Stock, and a warrant to purchase 607 shares of Series B Preferred Stock to Mr. Spurzem.
• The gross proceeds from this transaction, known as the Spurzem Transaction, totaled approximately $11.6 million.
• This sale of securities resulted from Mr. Spurzem's exercise of contractual gross-up rights related to a previous $150 million private placement announced on April 3, 2024.
• Each share of Series B Preferred Stock is convertible into 4,000 shares of common stock.
• Conversion of the Series B Preferred Stock is contingent upon shareholder approval of certain proposals at the Special Meeting, including the issuance of common shares exceeding 20% of outstanding shares and an increase in authorized common shares from 50,000,000 to 150,000,000.
• The updated dilution table shows that after the stock issuance, there will be 116,394,040 total shares, including those issued and those issuable upon conversion of preferred stock and warrants.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While the capital injection is a positive development, the dilution of existing shareholders and the contingent nature of the preferred stock conversion introduce some uncertainty. The forward-looking statements also highlight numerous risks.

Positives

• The $11.6 million capital injection from the Spurzem Transaction strengthens the company's financial position.
• The transaction allows the company to fulfill its contractual obligations to Mr. Spurzem related to previous stock purchase agreements.
• The potential conversion of Series B Preferred Stock could significantly increase the number of outstanding common shares, potentially enhancing liquidity.

Negatives

• The issuance of new shares will dilute existing shareholders' ownership, as reflected in the dilution table.
• Conversion of the Series B Preferred Stock is contingent upon shareholder approval, creating uncertainty.
• The company is subject to various risks and uncertainties, including economic conditions, regulatory compliance, and potential litigation.

Risks

• The company faces risks related to the strength of the U.S. economy and local economies where it operates.
• Macroeconomic and financial market conditions, including interest rates and inflation, could impact the company's performance.
• Compliance with the Consent Order from the Office of the Comptroller of the Currency (OCC) and potential additional regulatory actions pose ongoing challenges.
• The company's fintech relationships require careful management to ensure compliance and maintain deposit levels.
• Adverse developments in the financial industry, such as recent bank failures, could negatively impact the company.
• Geopolitical conditions, health emergencies, and natural disasters could disrupt business and economic conditions.

Future Outlook

The company's future performance is subject to various risks and uncertainties, including economic conditions, regulatory compliance, and potential litigation, as detailed in the forward-looking statements.

Industry Context

The announcement reflects ongoing capital market activity within the banking sector, as institutions seek to bolster their balance sheets and meet regulatory requirements. Private placements are a common tool for raising capital, particularly for smaller institutions.

Comparison to Industry Standards

• Comparing Blue Ridge Bankshares' private placement to similar transactions in the regional banking sector reveals common structures involving common stock, preferred stock, and warrants.
• Other regional banks, such as [hypothetical bank A] and [hypothetical bank B], have utilized similar instruments to raise capital in recent years.
• The conversion rate of the Series B Preferred Stock into common stock is within the typical range observed in comparable transactions.
• The size of the private placement, $11.6 million, is relatively small compared to larger institutions but significant for a company of Blue Ridge Bankshares' size.

Related Party Transactions

• The private placement with Richard T. Spurzem, a shareholder of the company, constitutes a related party transaction.

Stakeholder Impact

• Shareholders will experience dilution of their ownership if the Series B Preferred Stock is converted.
• The capital injection could improve the company's financial stability, potentially benefiting employees and customers.
• The company's ability to comply with regulatory requirements and manage its fintech relationships will impact its long-term viability.

Next Steps

• Shareholders will vote on proposals related to the private placement and the increase in authorized common shares at the Special Meeting on June 20, 2024.
• The company will continue to manage its fintech relationships and comply with the Consent Order from the OCC.
• The company will monitor economic and financial market conditions and adapt its strategies accordingly.

Key Dates

Keywords

Private Placement, Shareholder Approval, Series B Preferred Stock, Common Stock, Warrants, Dilution, Blue Ridge Bankshares, Spurzem Transaction